# Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®

> **NCT01352585** · — · COMPLETED · sponsor: **Shire** · enrollment: 47 (actual)

## Conditions studied

- Essential Thrombocythemia (ET)

## Interventions

- **DRUG:** Anagrelide hydrochloride

## Key facts

- **NCT ID:** NCT01352585
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-19
- **Primary completion:** 2013-09-19
- **Final completion:** 2013-09-19
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2021-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01352585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01352585, "Exploratory Multi-centre Trial In Patients With ET Treated With XAGRID®". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01352585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*